2m 2m 2m 2m 2m 2m 2m
ROCKET PHARMACTC (RCKT)
NASDAQ
$2.92+$0.02 (+0.87%)
Price as of Jun 03, 2026 6:32 PM EDT- $335.2MMarket Cap
- -2.36%1-Year Change
- BiotechnologyIndustry
ROCKET PHARMACTC (RCKT)
$2.92+$0.02 (+0.87%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -142.0M -17.07% | -171.2M -8.10% | -186.3M +12.55% | -165.6M +31.95% | |
Depreciation and Amortization Expense | 8.9M +22.85% | 7.2M +46.06% | 4.9M +25.74% | 3.9M +21.36% | |
Total Operating Expenses | 231.7M -15.17% | 273.2M +5.22% | 259.7M +15.74% | 224.3M +34.14% | |
Operating Profit | -231.7M -15.17% | -273.2M +5.22% | -259.7M +15.74% | -224.3M +34.14% | |
Interest Income | 3.2M -61.07% | 8.3M +56.34% | 5.3M +35.97% | 3.9M +26.76% | |
Interest Expense | -1.9M +0.27% | -1.9M +0.59% | -1.9M +0.70% | -1.9M -37.45% | |
Interest Income and Expense and Net | 1.3M -79.20% | 6.4M +86.96% | 3.4M +68.38% | 2.0M +2,127.47% | |
Total Nonoperating Income and Expense | 1.9M +0.27% | 1.9M +0.59% | 1.9M -24.40% | 2.5M -16.69% | |
Income before Taxes | -231.7M -15.17% | -273.2M +5.22% | -259.7M +15.74% | -224.3M +34.14% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -223.1M -13.77% | -258.7M +5.35% | -245.6M +10.70% | -221.9M +31.23% | |
Net Income from Continuing Operations Applicable to Common | -223.1M -13.77% | -258.7M +5.35% | -245.6M +10.70% | -221.9M +31.23% | |
Basic EPS and Net Income | -2.01 -26.37% | -2.73 -6.51% | -2.92 -10.43% | -3.26 +22.10% | |
Diluted EPS and Net Income | -2.01 -26.37% | -2.73 -6.51% | -2.92 -10.43% | -3.26 +22.10% | |
Basic Weighted Average Shares | 111.1M +17.21% | 94.8M +12.85% | 84.0M +23.27% | 68.1M +7.77% | |
Diluted Weighted Average Shares | 111.1M +17.21% | 94.8M +12.85% | 84.0M +23.27% | 68.1M +7.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 77.6M -52.60% | 163.6M +192.71% | 55.9M -60.22% | 140.5M -39.61% | |
Short-Term Investments | 111.4M -46.64% | 208.7M -34.22% | 317.3M +46.97% | 215.9M +38.34% | |
Cash and Cash Equivalents and Short-Term Investments | 188.9M -49.26% | 372.3M -0.22% | 373.2M +4.71% | 356.4M -8.32% | |
Total Current Assets | 192.7M -49.04% | 378.2M -0.01% | 378.2M +3.89% | 364.1M -7.14% | |
Accumulated Depreciation | 29.1M +37.03% | 21.3M +51.46% | 14.0M +54.32% | 9.1M +74.10% | |
Property and Plant and Equipment and Net | 28.2M -23.42% | 36.8M -6.09% | 39.2M +35.03% | 29.0M +30.09% | |
Total Long-Term Assets | 28.2M -23.42% | 36.8M -6.09% | 39.2M +35.03% | 29.0M +30.09% | |
Total Assets | 330.4M -37.38% | 527.7M -6.82% | 566.3M +2.63% | 551.8M +11.02% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 800,000 0.00% | 800,000 0.00% | 800,000 0.00% | 800,000 N/A | |
Total Current Liabilities | 30.2M -25.75% | 40.7M -16.12% | 48.5M +23.84% | 39.2M +76.70% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Long-Term Liabilities | 1.1M -7.10% | 1.1M -61.14% | 2.9M +13.14% | 2.6M +3,143.75% | |
Total Liabilities | 53.2M -17.43% | 64.5M -12.61% | 73.8M +18.75% | 62.1M +46.87% | |
Retained Earnings | -1.4B +18.32% | -1.2B +26.97% | -959.4M +34.41% | -713.8M +45.10% | |
Total Stockholders Equity | 277.2M -40.16% | 463.2M -5.96% | 492.6M +0.59% | 489.7M +7.69% | |
Total Shares Outstanding | 108.3M +1.75% | 106.5M +17.91% | 90.3M +14.11% | 79.1M +22.66% | |
Cash Flow | |||||
Cash from Operating Activities | -190.0M -9.40% | -209.7M +7.60% | -194.9M +9.42% | -178.1M +47.03% | |
Capital Expenditures | 440,000 -92.49% | 5.9M -64.33% | 16.4M +96.65% | 8.4M +9.69% | |
Cash from Investing Activities | 103.8M -21.21% | 131.7M +234.30% | -98.1M +41.46% | -69.3M -467.72% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 148,000 -99.92% | 185.7M -10.87% | 208.4M +34.20% | 155.3M +312.11% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -52.00% +9.94% | -47.30% +7.68% | -43.93% +3.83% | -42.31% +36.11% | |
Return on Equity | -60.27% +11.31% | -54.14% +8.27% | -50.01% +6.43% | -46.98% +33.15% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 6.38 -31.36% | 9.30 +19.21% | 7.80 -16.11% | 9.29 -47.45% | |
Cash Ratio | 2.57 -36.16% | 4.02 +248.99% | 1.15 -67.87% | 3.59 -65.82% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.002 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.001 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow